Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Pharmacogenetics of Leflunomide in the Management of Rheumatoid Arthritis

View source ↗

Summary

A recruiting clinical trial investigating pharmacogenetics of Leflunomide to optimize management of rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARAVA (leflunomide)

Snippet

Sponsor: Foundation University Islamabad | Conditions: Rhematoid Arthritis | Status: RECRUITING